These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20237027)

  • 1. Positron emission tomography in schizophrenia: a new perspective.
    Patel NH; Vyas NS; Puri BK; Nijran KS; Al-Nahhas A
    J Nucl Med; 2010 Apr; 51(4):511-20. PubMed ID: 20237027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional brain imaging in schizophrenia.
    Cleghorn JM; Zipursky RB; List SJ
    J Psychiatry Neurosci; 1991 Jul; 16(2):53-74. PubMed ID: 1911736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride.
    Gründer G; Siessmeier T; Piel M; Vernaleken I; Buchholz HG; Zhou Y; Hiemke C; Wong DF; Rösch F; Bartenstein P
    J Nucl Med; 2003 Jan; 44(1):109-16. PubMed ID: 12515884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
    Buchsbaum MS; Christian BT; Lehrer DS; Narayanan TK; Shi B; Mantil J; Kemether E; Oakes TR; Mukherjee J
    Schizophr Res; 2006 Jul; 85(1-3):232-44. PubMed ID: 16713185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches.
    Kumakura Y; Cumming P
    Neuroscientist; 2009 Dec; 15(6):635-50. PubMed ID: 19793723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorder.
    Cumming P; Abi-Dargham A; Gründer G
    Behav Brain Res; 2021 Feb; 398():113004. PubMed ID: 33197459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.
    Erritzoe D; Talbot P; Frankle WG; Abi-Dargham A
    Neuroimaging Clin N Am; 2003 Nov; 13(4):817-32. PubMed ID: 15024964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.
    Gründer G; Fellows C; Janouschek H; Veselinovic T; Boy C; Bröcheler A; Kirschbaum KM; Hellmann S; Spreckelmeyer KM; Hiemke C; Rösch F; Schaefer WM; Vernaleken I
    Am J Psychiatry; 2008 Aug; 165(8):988-95. PubMed ID: 18381901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Background and findings of neuroimaging in schizophrenia: an update].
    Cuevas-Esteban J; Campayo A; Gutiérrez-Galve L; Gracia-García P; López-Antón R
    Rev Neurol; 2011 Jan; 52(1):27-36. PubMed ID: 21246491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H1 receptors in schizophrenic patients measured by positron emission tomography.
    Iwabuchi K; Ito C; Tashiro M; Kato M; Kano M; Itoh M; Iwata R; Matsuoka H; Sato M; Yanai K
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):185-91. PubMed ID: 15695063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
    Kegeles LS; Slifstein M; Frankle WG; Xu X; Hackett E; Bae SA; Gonzales R; Kim JH; Alvarez B; Gil R; Laruelle M; Abi-Dargham A
    Neuropsychopharmacology; 2008 Dec; 33(13):3111-25. PubMed ID: 18418366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain dopamine d1 receptors in twins discordant for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Aalto S; Någren K; Huttunen M; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
    Am J Psychiatry; 2006 Oct; 163(10):1747-53. PubMed ID: 17012685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroimaging in schizophrenia].
    Lanzenberger R; Kasper S
    Fortschr Neurol Psychiatr; 2005 Nov; 73 Suppl 1():S51-9. PubMed ID: 16270245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia?
    Vyas NS; Patel NH; Nijran KS; Al-Nahhas A; Puri BK
    Nucl Med Commun; 2010 Feb; 31(2):91-3. PubMed ID: 19949353
    [No Abstract]   [Full Text] [Related]  

  • 15. Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography.
    Kim JJ; Mohamed S; Andreasen NC; O'Leary DS; Watkins GL; Boles Ponto LL; Hichwa RD
    Am J Psychiatry; 2000 Apr; 157(4):542-8. PubMed ID: 10739412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
    Karlsson P; Farde L; Halldin C; Sedvall G
    Am J Psychiatry; 2002 May; 159(5):761-7. PubMed ID: 11986129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Brain imaging in schizophrenia -- especially by Computed Tomography].
    Szulc A
    Psychiatr Pol; 1994; 28(2):145-56. PubMed ID: 8208861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroreceptor imaging studies in schizophrenia.
    Frankle WG
    Harv Rev Psychiatry; 2007; 15(5):212-32. PubMed ID: 17924257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia.
    Yasuno F; Suhara T; Okubo Y; Ichimiya T; Takano A; Sudo Y; Inoue M
    Psychiatry Res; 2005 Apr; 138(3):197-207. PubMed ID: 15854788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cingulate gyrus volume and metabolism in the schizophrenia spectrum.
    Haznedar MM; Buchsbaum MS; Hazlett EA; Shihabuddin L; New A; Siever LJ
    Schizophr Res; 2004 Dec; 71(2-3):249-62. PubMed ID: 15474896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.